missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Rivastigmine tartrate, Tocris Bioscience™
Click to view available options
Quantity:
50 mg
Description
Rivastigmine tartrate is a cholinesterase inhibitor; inhibits both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) (IC50 ranges are 4.3-4760 nM and 16-238 nM respectively). Rivastigmine increases α-secretase activity and directs APP processing to the non-amyloidogenic pathway. Brain penetrant.
Specifications
Specifications
CAS | 129101-54-8 |
Molecular Formula | C18H28N2O8 |
MDL Number | MFCD03700731 |
Quantity | 50 mg |
Synonym | rivastigmine tartrate, rivastigmine bitartrate, sdz-ena 713, rivastigmine hydrogen tartrate, rivastigmine hydrogentartrate, unii-9iy2357jpe, s-3-1-dimethylamino ethyl phenyl ethyl methyl carbamate 2r,3r-2,3-dihydroxysuccinate, rivastigmine tartrate exelon, carbamic acid, ethylmethyl-, 3-1s-1-dimethylamino ethyl phenyl ester, 2r,3r-2,3-dihydroxybutanedioate 1:1 |
InChI Key | GWHQHAUAXRMMOT-RWALOXMOSA-N |
SMILES | O[C@@H]([C@H](O)C(O)=O)C(O)=O.CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C |
IUPAC Name | (2S,3S)-2,3-dihydroxybutanedioic acid; 3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate |
Molecular Weight (g/mol) | 400.43 |
PubChem CID | 6918078 |
Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction